83 FR 47180 - Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 83, Issue 181 (September 18, 2018)

Page Range		47180-47180
FR Document		2018-20269

The Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) has scheduled a public meeting. Information about the CHACHSPT can be found here: https://www.cdc.gov/maso/facm/ facmchachspt.html. An agenda may be requested by emailing [email protected]

Federal Register, Volume 83 Issue 181 (Tuesday, September 18, 2018)

[Federal Register Volume 83, Number 181 (Tuesday, September 18, 2018)]
[Notices]
[Page 47180]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-20269]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC)/HRSA 
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment (CHACHSPT) has scheduled a public meeting. Information about 
the CHACHSPT can be found here: https://www.cdc.gov/maso/facm/facmchachspt.html. An agenda may be requested by emailing 
[email protected].

DATES: November 7, 2018, 8:30 a.m.-5:00 p.m. ET and November 8, 2018, 
8:30 a.m.-3:30 p.m. ET.

ADDRESSES: This meeting will be held in-person and by webinar and 
teleconference. The address for the meeting is DoubleTree by Hilton, 
Bethesda, 8120 Wisconsin Avenue, Bethesda, Maryland 20814.
     Adobe Connect URL link: https://hrsa.connectsolutions.com/chac_meeting/.
     Conference call-in number: 888-324-9617, Passcode 9245865.

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Chief, Policy 
Development Branch, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and 
Data, 5600 Fishers Lane, Room 9N156, or by email at 
[email protected].

SUPPLEMENTARY INFORMATION: The CHACHSPT was established under Section 
222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], 
as amended.
    The purpose of the CHACHSPT is to advise the Secretary of HHS, the 
Director of the CDC, and the Administrator of HRSA on the objectives, 
strategies, policies, and priorities for HIV, viral hepatitis, and 
other STD prevention and treatment efforts. This includes, but is not 
limited to, surveillance of HIV infection, viral hepatitis, and other 
STDs; responses to related emerging health needs; and epidemiologic, 
behavioral, health services, and laboratory research on HIV/AIDS, viral 
hepatitis, and other STDs. The CHACHSPT also provides advice regarding 
policy issues related to HIV/viral hepatitis/STD professional 
education, patient healthcare delivery, research and training, and 
prevention services.
    During the November 7-8, 2018, meeting, the CHACHSPT will discuss 
the following topics:
     CHACHSPT workgroup reports and findings;
     updates from CDC, HRSA, and HRSA HAB;
     strategies for serving women, infants, children, and 
youth;
     agencies' responses to the opioid crisis; and
     telemedicine initiatives.

Agenda items are subject to change as priorities dictate. Refer to the 
CHACHSPT website for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to CHACHSPT should be 
sent by email to [email protected] or by mail to Theresa 
Jumento at the address above at least 3 business days prior to the 
meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Theresa Jumento at the 
address listed above at least 10 business days prior to the meeting.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-20269 Filed 9-17-18; 8:45 am]
BILLING CODE 4165-15-P

47180 Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices

the committee. Oral presentations from DEPARTMENT OF HEALTH AND HIV/viral hepatitis/STD professional
the public will be scheduled between HUMAN SERVICES education, patient healthcare delivery,
approximately 8:30 a.m. and 10:30 a.m. research and training, and prevention
on October 25, 2018. Those individuals Health Resources and Services services.
interested in making formal oral Administration During the November 7–8, 2018,
presentations should notify the contact meeting, the CHACHSPT will discuss
Meeting of the CDC/HRSA Advisory the following topics:
person and submit a brief statement of
Committee on HIV, Viral Hepatitis and
the general nature of the evidence or • CHACHSPT workgroup reports and
STD Prevention and Treatment
arguments they wish to present, the findings;
names and addresses of proposed AGENCY: Health Resources and Services • updates from CDC, HRSA, and
participants, and an indication of the Administration (HRSA), Department of HRSA HAB;
approximate time requested to make Health and Human Services (HHS). • strategies for serving women,
their presentation on or before October ACTION: Notice. infants, children, and youth;
1, 2018. Time allotted for each • agencies’ responses to the opioid
presentation may be limited. If the SUMMARY: The Centers for Disease crisis; and
number of registrants requesting to Control and Prevention (CDC)/HRSA • telemedicine initiatives.
speak is greater than can be reasonably Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Agenda items are subject to change as
accommodated during the scheduled priorities dictate. Refer to the
Treatment (CHACHSPT) has scheduled
open public hearing session, FDA may CHACHSPT website for any updated
a public meeting. Information about the
conduct a lottery to determine the CHACHSPT can be found here: https:// information concerning the meeting.
speakers for the scheduled open public www.cdc.gov/maso/facm/ Members of the public will have the
hearing session. The contact person will facmchachspt.html. An agenda may be opportunity to provide comments.
notify interested persons regarding their requested by emailing Public participants may submit written
request to speak by October 2, 2018. CHACAdvisoryComm@hrsa.gov. statements in advance of the scheduled
Persons attending FDA’s advisory DATES: November 7, 2018, 8:30 a.m.–
meeting. Oral comments will be
committee meetings are advised that 5:00 p.m. ET and November 8, 2018, honored in the order they are requested
FDA is not responsible for providing 8:30 a.m.–3:30 p.m. ET. and may be limited as time allows.
access to electrical outlets. Requests to submit a written statement
ADDRESSES: This meeting will be held
or make oral comments to CHACHSPT
For press inquiries, please contact the in-person and by webinar and should be sent by email to
Office of Media Affairs at fdaoma@ teleconference. The address for the CHACAdvisoryComm@hrsa.gov or by
fda.hhs.gov or 301–796–4540. meeting is DoubleTree by Hilton, mail to Theresa Jumento at the address
Bethesda, 8120 Wisconsin Avenue, above at least 3 business days prior to
FDA welcomes the attendance of the
Bethesda, Maryland 20814. the meeting.
public at its advisory committee
• Adobe Connect URL link: https://
meetings and will make every effort to Individuals who plan to attend and
hrsa.connectsolutions.com/chac_
accommodate persons with disabilities. need special assistance or another
meeting/.
If you require accommodations due to a reasonable accommodation should
• Conference call-in number: 888–
disability, please contact LaToya Bonner notify Theresa Jumento at the address
324–9617, Passcode 9245865.
(see FOR FURTHER INFORMATION CONTACT) listed above at least 10 business days
FOR FURTHER INFORMATION CONTACT: prior to the meeting.
at least 7 days in advance of the Theresa Jumento, Chief, Policy
meeting. Development Branch, HRSA, HIV/AIDS Amy P. McNulty,
FDA is committed to the orderly Bureau (HAB), Division of Policy and Acting Director, Division of the Executive
conduct of its advisory committee Data, 5600 Fishers Lane, Room 9N156, Secretariat.
meetings. Please visit our website at or by email at CHACAdvisoryComm@ [FR Doc. 2018–20269 Filed 9–17–18; 8:45 am]
https://www.fda.gov/ hrsa.gov. BILLING CODE 4165–15–P
AdvisoryCommittees/ SUPPLEMENTARY INFORMATION: The
AboutAdvisoryCommittees/ CHACHSPT was established under
ucm111462.htm for procedures on DEPARTMENT OF HEALTH AND
Section 222 of the Public Health Service HUMAN SERVICES
public conduct during advisory (PHS) Act, [42 U.S.C. Section 217a], as
committee meetings. amended. National Advisory Council on Migrant
Notice of this meeting is given under The purpose of the CHACHSPT is to Health
the Federal Advisory Committee Act (5 advise the Secretary of HHS, the
U.S.C. app. 2). Director of the CDC, and the AGENCY: Health Resources and Services
Administrator of HRSA on the Administration (HRSA), Department of
Dated: September 13, 2018. objectives, strategies, policies, and Health and Human Services (HHS).
Leslie Kux, priorities for HIV, viral hepatitis, and ACTION: Meeting notice.
Associate Commissioner for Policy. other STD prevention and treatment
[FR Doc. 2018–20233 Filed 9–17–18; 8:45 am] efforts. This includes, but is not limited SUMMARY: The Secretary’s National
to, surveillance of HIV infection, viral Advisory Council on Migrant Health
daltland on DSKBBV9HB2PROD with NOTICES

BILLING CODE 4164–01–P
hepatitis, and other STDs; responses to (NACMH) has scheduled a public
related emerging health needs; and meeting. Information about NACMH
epidemiologic, behavioral, health and the agenda for this meeting can be
services, and laboratory research on found on the NACMH website at:
HIV/AIDS, viral hepatitis, and other https://bphc.hrsa.gov/quality
STDs. The CHACHSPT also provides improvement/strategicpartnerships/
advice regarding policy issues related to nacmh/index.html.

VerDate Sep<11>2014 19:14 Sep 17, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\18SEN1.SGM 18SEN1

Document Created: 2018-09-18 01:18:20
Document Modified: 2018-09-18 01:18:20

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		November 7, 2018, 8:30 a.m.-5:00 p.m. ET and November 8, 2018, 8:30 a.m.-3:30 p.m. ET.
Contact		Theresa Jumento, Chief, Policy Development Branch, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and Data, 5600 Fishers Lane, Room 9N156, or by email at [email protected]
FR Citation		83 FR 47180

83 FR 47180 - Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment

DEPARTMENT OF HEALTH AND HUMAN SERVICESHealth Resources and Services Administration

Federal Register Volume 83, Issue 181 (September 18, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration